Lisinopril and Hydrochlorothiazide
- Product NDC
- 50268-481
- 11-digit product format
- 502680481
- Labeler code
- 50268
- Product ID
- 50268-481_ed8533da-b1f7-8296-e053-2a95a90aca68
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lisinopril and Hydrochlorothiazide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- AvPAK
- Application
- ANDA077912
- Marketing category
- ANDA
- Marketing start
- 2021-04-23
- Marketing end
- 2022-11-30
- Substance
- HYDROCHLOROTHIAZIDE; LISINOPRIL
- Active strength
- 25 mg/1; mg/1
- Pharmacologic classes
- Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50268-481-15 | 50268048115 | 50 BLISTER PACK in 1 BOX (50268-481-15) > 1 TABLET in 1 BLISTER PACK (50268-481-11) | 50 blister pack | 2021-04-23 | 0000-00-00 | No | No | Current |